Perspective Therapeutics (CATX) Other Non Operating Income (2010 - 2025)

Perspective Therapeutics' (CATX) quarterly Other Non Operating Income came in at $1.4 million in Q1 2025, up 69900.0% quarter-over-quarter from $2000.0 in Q2 2023.

Perspective Therapeutics (CATX) Other Non Operating Income (2010 - 2025) Analysis & Trends

Perspective Therapeutics has disclosed Other Non Operating Income across 10 years of filings, most recently posting $1.4 million for Q1 2025.

  • Other Non Operating Income for Q1 2025 came in at $1.4 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $1.4 million (changed N/A YoY), and the FY2025 annual result was $1.4 million, changed N/A from the prior year.
  • Other Non Operating Income came in at $1.4 million for Q1 2025 at Perspective Therapeutics, up from $2000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $1.4 million in Q1 2025 to a low of $2000.0 in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Perspective Therapeutics 308.74 Mn 308.74 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2025 1.40 Mn
Jun 30, 2023 2,000.00
Mar 31, 2019 2,000.00
Sep 30, 2016 27,000.00
Jun 30, 2016 18,000.00
Mar 31, 2016 78,000.00
Sep 30, 2015 15,000.00
Jun 30, 2015 -605.00
Mar 31, 2015 28,605.00
Dec 31, 2014 41,000.00
Sep 30, 2014 306,000.00
Jun 30, 2014 -368,134.00
Mar 31, 2014 -1.10 Mn
Dec 31, 2013 117,000.00
Sep 30, 2013 -36,000.00
Jun 30, 2013 25,000.00
Mar 31, 2013 109,000.00
Dec 31, 2012 -55,000.00
Sep 30, 2012 -11,000.00
Jun 30, 2012 18,650.00